TWIST BIOSCIENCE ($TWST) posted quarterly earnings results for Q2 2026 on Monday, May 4th. The company reported earnings of -$0.62 per share, missing estimates of -$0.49 by $0.13. The company also reported revenue of $110,720,000, beating estimates of $109,810,364 by $909,636.
You can see Quiver Quantitative's $TWST stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TWIST BIOSCIENCE Insider Trading Activity
TWIST BIOSCIENCE insiders have traded $TWST stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.
Here’s a breakdown of recent trading of $TWST stock by insiders over the last 6 months:
- PATRICK JOHN FINN (President and COO) has made 0 purchases and 13 sales selling 113,737 shares for an estimated $5,467,301.
- PAULA GREEN (SVP of Human Resources) has made 0 purchases and 9 sales selling 46,127 shares for an estimated $2,334,115.
- EMILY M. LEPROUST (Chief Executive Officer) has made 0 purchases and 11 sales selling 37,452 shares for an estimated $1,746,147.
- ADAM LAPONIS (Chief Financial Officer) has made 0 purchases and 8 sales selling 25,307 shares for an estimated $1,222,004.
- ROBERT CHESS has made 0 purchases and 2 sales selling 12,184 shares for an estimated $575,402.
- ROBERT F. WERNER (Chief Accounting Officer) has made 0 purchases and 8 sales selling 10,555 shares for an estimated $460,550.
- DENNIS CHO (See Remarks) has made 0 purchases and 9 sales selling 10,220 shares for an estimated $452,525.
- JAN JOHANNESSEN has made 0 purchases and 2 sales selling 9,244 shares for an estimated $279,874.
- MELISSA A. STAROVASNIK sold 500 shares for an estimated $30,915
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
TWIST BIOSCIENCE Hedge Fund Activity
We have seen 118 institutional investors add shares of TWIST BIOSCIENCE stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,321,688 shares (-73.9%) from their portfolio in Q4 2025, for an estimated $105,363,943
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 1,812,146 shares (+43.7%) to their portfolio in Q4 2025, for an estimated $57,481,271
- EDGEPOINT INVESTMENT GROUP INC. added 1,295,672 shares (+31.7%) to their portfolio in Q4 2025, for an estimated $41,098,715
- ARK INVESTMENT MANAGEMENT LLC added 832,687 shares (+12.4%) to their portfolio in Q4 2025, for an estimated $26,412,831
- JPMORGAN CHASE & CO removed 803,087 shares (-78.9%) from their portfolio in Q4 2025, for an estimated $25,473,919
- MORGAN STANLEY removed 625,750 shares (-41.9%) from their portfolio in Q4 2025, for an estimated $19,848,790
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 580,695 shares (-9.1%) from their portfolio in Q4 2025, for an estimated $18,419,645
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
TWIST BIOSCIENCE Analyst Ratings
Wall Street analysts have issued reports on $TWST in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 11/17/2025
To track analyst ratings and price targets for TWIST BIOSCIENCE, check out Quiver Quantitative's $TWST forecast page.
TWIST BIOSCIENCE Price Targets
Multiple analysts have issued price targets for $TWST recently. We have seen 4 analysts offer price targets for $TWST in the last 6 months, with a median target of $55.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $55.0 on 04/14/2026
- Vijay Kumar from Evercore ISI Group set a target price of $56.0 on 04/06/2026
- Subbu Nambi from Guggenheim set a target price of $55.0 on 03/30/2026
- Brendan Smith from TD Cowen set a target price of $43.0 on 01/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
